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The glycoprotein from Friend murine leukemia virus was digested with protease from Staphylococcus 
aureus V8. A glycopeptide comprising the N-terminal glycosylation site (Asn-12) was isolated from the 
mixture of fragments and analyzed by amino acid sequencing and methylation-capillary gas 
chromatography-mass spectrometry before and after treatment with sialidase from vibrio cholerae. 
Asn-12 was thus found to be substituted by a family of partially sialylated, fucosylated, and intersected 
glycoprotein N-glycans of the hybrid type. 
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1. INTRODUCTION 
The MuLVs are enveloped RNA viruses (type C 
retroviruses), the surface of which is studded with 
‘spikes’ consisting mainly of one glycopolypeptide 
[l]. Because of the intriguing multitude of 
biological functions associated with these viral gps, 
notably because of their possible implication in 
leukemogenesis [l-3], the amino acid sequences of 
the gps of several MuLV strains have been 
established, including that of the gp71 of the 
ecotropic F-MuLV [4], which was found to com- 
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prise 8 potential N-glycosylation sites [5,6]. In ad- 
dition, we [7,8] recently elucidated the structures 
of the desialylated N-glycans from the isoglycopro- 
teins (gp71 and gp69) [3,9,10] of helper- 
independent Friend virus [4] as produced by 
Eveline suspension cells [ 1 l] in amounts sufficient 
for carbohydrate analysis. For a complete struc- 
ture determination of F-MuLV gp71, therefore, 
the assignment of oligosaccharides to specific Asn- 
X-Ser/Thr sequences in these isoglycoproteins, as 
well as their degree of sialylation remain to be 
established. We report here on the structure of the 
carbohydrate unit linked to Asn-12, at the N- 
terminal sequence of F-MuLV gp7 1. 
2. MATERIALS AND METHODS 
2.1. Preparation and proteolysis of viral 
glycoprotein 
As detailed in [7, IO], the mixture of isoglycopro- 
teins gp71 and gp69 was isolated from particles of 
helper-independent Friend virus [4] as produced by 
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Eveline cells [ 111. Samples (about 5 mg) of reduced 
and carboxymethylated gp7 1 /gp69 were digested 
(24 h at 37’C) with protease from S. aureus V8 
(60rg; Miles, Elkhart, IN) in 0.2 M ammonium 
bicarbonate buffer of pH 8.2 (repeated once). 
2.2. Fractionation of (glyco)peptides 
The digests were prefractionated through a col- 
umn (1.6 x 170 cm) of Biogel P-30 (100-200 mesh; 
BioRad, Richmond, CA) at 25°C employing a 
10 mM ammonium acetate buffer of pH 6.0 (con- 
taining 0.2 g/l NaN3). 
A Waters (Milford, MA) system (model 6000A 
pumps, model 660 solvent programmer and model 
U6K injector) combined with a Gynkotek 
(Munich) photometer (model SP4) served for the 
subfractionation by rHPLC. Essentially, the con- 
ditions described in [ 121 were employed, i.e., a col- 
umn (0.46 x 25 cm) of ODS-Hypersil (3~; Shan- 
don, Runcorn, England) and a linear gradient of 
acetonitrile in the ammonium acetate buffer. 
Peak fractions were collected as recorded by 
continuous flow-monitoring of absorbance at 
220 nm. 
2.3. Digestion with sialidase 
The enzyme from V. cholerae (Behringwerke, 
Marburg) was used; for experimental details see 
v31. 
2.4. Protein analytical methods 
The amino acid (or hexosamine) composition of 
(glyco)peptides was determined with a Biotronik 
(Frankfurt) model LC 6001 analyzer after 24 h (or 
2 h) of hydrolysis at 110°C (or 1OO’C) in 6 N (or 
4 N) aqueous HCl, using o-phthaldialdehyde as a 
colouring reagent. 
The amino acid sequence analysis of the N- 
terminal glycopeptide was performed with a Se- 
quemat (Watertown, MA) solid-phase sequencer 
(model Mini 15) after coupling to aminopropyl 
glass with 1-ethyl-3-dimethylaminopropylcarbodi- 
imide (both Pierce, Rockford, IL) [14]. The PTH 
amino acids were identified by rHPLC using the 
Waters equipment including an absorbance detec- 
tor (model 440) coupled to a Hewlett Packard 
(Palo Alto, CA) integrator (model 3380A), and 
following the experimental details in [15], except 
that a longer column (0.46 x 40 cm) of LiChrosorb 
RP-18 (5 p; Merck, Darmstadt) was employed. 
2.5. Carbohydrate analytical methods 
The N-terminal glycopeptide was permethylated 
as in [16], and the partially methylated alditol 
acetates obtained after hydrolysis etc. were anal- 
yzed by GC-MS [ 171, using the micromethylation- 
capillary GC-MS version of this technique and the 
instrumentation detailed in [ 181. 
3. RESULTS 
3.1. Isolation of N-terminal glycopeptide of 
F-MUL V gp7I 
Under appropriate conditions, the protease of S. 
aureus V8 cleaves proteins almost exclusively at the 
C-termini of Glu residues. The fragments obtained 
by the action of this enzyme on F-MuLV gp71 
could thus be expected to comprise glycopeptides 
with the following N-glycosylation sites: Ala-l 
- -Asn-12. .Glu-16 (Mr 2500-3500), Thr-148. - 
Asn-168 - . Asn-266. ~Asn-302. - Glu-311 (Mr 
21000-24000), Gly-324. -Asn-334. -Asn-341 
- . Glu-354 (MI 5000-7000), and Val-355. . Asn-374 
. -Asn-410. -Glu-420 (Mr 9000-10000) (cf. [5,6]). 
For the isolation of an N-terminal glycopeptide of 
F-MuLV gp71 containing only the first N-glyco- 
sylation site (Asn-12), the following strategy was 
adopted: The mixture of isoglycoproteins gp71 and 
gp69 was digested with S. aureus protease, and the 
products were prefractionated by gel filtration; the 
peak material comprising fragments of Mr about 
2000-4000 was collected and subjected to rHPLC. 
A fraction containing glucosamine was thus iso- 
lated (fig.l), the microheterogeneity of which ap- 
pears to be due to variations in glycosylation, 
because it is diminished by sialidase treatment. 
3.2. Amino acid sequence of N-terminal 
glycopeptide 
The glycopeptide thus isolated was found to 
contain Asx, Thr, Ser, Glx, Gly, Ala, Val, Ile, Tyr, 
His, and GlcN in molar ratios approaching 
1:1:2:2:1:2:1:1:1:1:3 (ProandTrpnot deter- 
mined), and was sequenced with the results shown 
in table 1. 
3.3. Analysis of carbohydrate moiety in 
N-terminal glycopeptide 
The glycopeptide (fig. 1 b) and its sialidase diges- 
tion product (fig. lc) were permethylated, 
hydrolyzed, reduced with NaBI&, and pera- 
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Fig.1. Isolation of N-terminal glycopeptide from F- 
MuLV gp71. (a) Biogel P-30 chromatography of F- 
MuLV gp71/gp69 after digestion with protease from S. 
aureus V8. (b) Subfractionation of gp fragments with M, 
around 2000-4000 (bracket in a) by rHPLC; only the 
microheterogeneous, hatched fraction was found to 
contain glucosamine. (c) rHPLC of glycopeptide 
fraction (hatched peak in b) after treatment with 
sialidase from I’. cholerae. 
Table 1 
Amino acid sequence of N-terminal glycopeptide of F- 
MuLV gp71 (data not corrected for background) 
Step 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Amino acid Yield 
identified (pmol) 
A 2800 
A 2300 
P 900 
G 910 
S 530 
S 690 
(L& 
960 
_” 
Q 1200 
V 720 
(:)a 
510 
_ b 
I 140 
T 180 
(;a 
110 
_ b 
a Assigned on the basis of the known sequence [5,6,10] 
b Not identified 
cetylated, and the partially methylated hexitol 
acetates obtained were analyzed by GC-MS. The 
results are presented in table 2. 
4. DISCUSSION 
A comparison of the amino acid sequence data 
presented in table 1 with those published for gp71 
of ecotropic F-MuLV [5,6,10] and for two smaller 
isoglycoproteins also found in helper-independent 
Friend virus as produced by Eveline cells 13,101 
clearly shows that the glycopeptide isolated here 
constitutes the N-terminus of the former glycopro- 
tein. In addition, these data confirm that the pep- 
tide portion of the glycopeptide is homogeneous. 
A comparison of the methylation results shown 
in table 2, on the other hand, with the structures of 
the desialylated oligosaccharides as obtained from 
total gp71/gp69 [7,8], leads to the conclusion that 
it is mainly the endo H-sensitive [20] glycans of the 
‘mixed type’ [21] previously designated ‘Mm’ and 
‘Mrv’ [8] which are linked to Asn-12 of gp71. 
However, as evidenced by the detection 
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Table 2 
Methylation analysis of N-terminal glycopeptide from 
F-MuLV gp7 1 
Peracetate ofa Peak ratiob obtained from 
glycopeptide 
Before 
digestion 
with sialidase 
After 
2,3,4-FucOH 
2,3,4,6-ManOH 
3,4,6-ManOH 
2,4,6-ManOH 
2,4-ManOH 
2-ManOH 
2,3,4,6-GalOH 
2,4,6-GalOH 
2,3,4-GalOH 
0.3 
1.4 
1.0b 
0.15 
1.45= 
O.lC 
0.6 
0.4 
trace 
0.3 
1.2 
1.0b 
0.2 
1.3c 
O.lC 
1.0 
- 
- 
3,4,6-GlcN(Me)AcOH 0.15 0.3 
3,dGlcN(Me)AcOH 2.6 2.5 
3-GlcN(Me)AcOH 0.1 0.1 
a 2,3,4,6-ManOH, 2,3,4,6-tetra-O-methylmannitol etc.; 
3,4,6_GlcN(Me)AcOH, 2-deoxy-2-(N-methylacetami- 
do)-3 4,6-tri-0-methylglucitol etc. 
b As detected by flame ionization; based on 
3,4,6-ManOH = 1.0 
’ Corrected for loss during hydrolysis [19] 
[=(2+3) 
of 2,4,6GalOH before but not after sialidase 
treatment, and of 2,3,4-FucOH and 3- 
GlcN(Me)AcOH, respectively, these oligosac- 
charides are partially sialylated and fucosylated in 
the native glycoprotein. In addition, and also in 
agreement with our earlier results [8], a minority of 
the hybrid glycans in the N-terminal glycopeptide 
appear to carry intersecting GlcNAc residues [see 
values for 2-ManOH and 3,4,6GlcN(Me)AcOH]. 
The structure of the N-terminal glycopeptide of 
F-MuLV gp71 may thus be summarized as shown 
in scheme 1. 
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